




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Acute Heart Failure</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=729dd08e-0a1b-4aa5-bd2a-5e3f31006cb0</link>
        <description>Clinical Topic Feed: Acute Heart Failure</description>
        <language>en</language>

        

                <item>
                    <title>Sex Differences in HFimpEF Prevalence, Outcomes</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/21/17/12/Sex-Differences-in-HFimpEF-Prevalence-Outcomes</link>                    <description>Heart failure with improved ejection fraction (HFimpEF) was associated with better outcomes than persistent heart failure with reduced ejection fraction (HFrEF) in both women and men, according to research published Oct. 15 in JACC: Heart Failure.</description>
                    <pubdate>1792674540000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: The new ACC Scientific Statement on Exercise Prescription for CV Health, Multimodality Cardiac Imagine, Risk Stratification &amp; CMR, Preventive PCI and CV Risk</title>
<link>/Latest-in-Cardiology/Articles/2026/10/21/13/48/eagles-eye-view-21oct2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at the new ACC Scientific Statement on Exercise Prescriptions for Cardiovascular Health in Adults.&#226;€&#175;He then examines a recent State-of-the-Art Review on the evolving role of multimodality cardiovascular imaging in the diagnosis and management of cardiac sarcoidosis (CS).</description>
                    <pubdate>1792590660000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HFSA 2026: ATTRibute-CM Analysis; LINK-HF2 Results; More</title>
<link>/Latest-in-Cardiology/Articles/2026/10/19/18/12/HFSA-2026</link>                    <description>New science presented at HFSA 2026 and simultaneously published in JACC: Heart Failure spans several evolving areas in heart failure (HF), from ATTR-CM biomarkers and measures of physical function to predictors of adverse outcomes in transplant recipients to artificial intelligence (AI) wearables enhancing discharge care following HF hospitalization.</description>
                    <pubdate>1792523820000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ENCIRCLE MAC Registry: One-Year TMVR Outcomes</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/14/09/58/ENCIRCLE-MAC-Registry</link>                    <description>Transseptal transcatheter mitral valve replacement (TMVR) with the SAPIEN M3 system among patients with symptomatic mitral annular calcification (MAC)-related mitral valve dysfunction (MVD) was associated with sustained mitral regurgitation (MR) reduction and improved symptoms and quality of life at one year...</description>
                    <pubdate>1791996240000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CONDUCT-AF: Conduction System Pacing Noninferior to Biventricular Pacing After AVNA</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/14/09/58/CONDUCT-AF</link>                    <description>In patients with heart failure (HF) and refractory atrial fibrillation (AFib) undergoing atrioventricular node ablation (AVNA), conduction system pacing (CSP) with left bundle branch area pacing (LBBAP) was noninferior to biventricular pacing (BVP) for improving LVEF, according to results from the CONDUCT-AF trial published Oct. 6 in EHJ.</description>
                    <pubdate>1791985800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CMR-Based Risk Stratification in Excessive LV Trabeculation</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/14/09/58/CMR-Based-Risk-Stratification-in-Excessive-LV-Trabeculation</link>                    <description>A risk stratification model based on cardiac magnetic resonance (CMR) results demonstrated moderate prognostic performance in excessive trabeculation of the left ventricle (ETLV), driven primarily by adverse LV remodeling and fibrosis, according to research published Oct. 7 in JACC: Cardiovascular Imaging.</description>
                    <pubdate>1791983820000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: ACC/AHA Joint Perioperative Guidelines; Atenolol and MACE Risk; Yoga and VPCs; DECIPHER &amp; CMR</title>
<link>/Latest-in-Cardiology/Articles/2026/10/07/14/58/eagles-eye-view-07oct2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at how the most recent perioperative guideline published in 2024 remains valid and current.</description>
                    <pubdate>1791385140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Racial, Ethnic and Place-Based Disparities in CVD Mortality in the US</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/20/22/Racial-Ethnic-and-Place-Based-Disparities-in-CVD-Mortality</link>                    <description>Despite sustained declines in overall cardiovascular disease mortality in the U.S., racial, ethnic and place-based disparities persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC.</description>
                    <pubdate>1791383400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PCM GENES: Pediatric HCM, Severe LVH and Gene Variants</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/13/56/PCM-GENES</link>                    <description>Severe left ventricular hypertrophy (LVH) was associated with younger age at enrollment and a higher likelihood of a pathogenic variant in MYBPC3 in children with hypertrophic cardiomyopathy (HCM), according to research published Sept. 24 in JACC: Heart Failure.</description>
                    <pubdate>1791308400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Aficamten For Symptomatic Nonobstructive HCM: ACACIA-HCM Trial</title>
<link>/Latest-in-Cardiology/Articles/2026/10/06/12/20/accel-lite-06oct2026</link>                    <description>In this episode, Matthew Martinez, MD, FACC and Ahmad Masri, MD, FACC evaluate &#226;€œACACIA-HCM: Aficamten for symptomatic nonobstructive hypertrophic cardiomyopathy&#226;€.</description>
                    <pubdate>1791300600000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>